OPA-15406 ointment

OPA-15406 · Otsuka Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for OPA-15406 ointment, covering 2020-06-29 to 2025-08-29. Get the full timeline:

Most recent: Clinical Trial Update: To Demonstrate the Superiority of IMP (1% OPA-15406 Ointment) to the Vehicle in Adult Patients With AD [Phase 3]